KFAS
TECH icon

Keating Financial Advisory Services’s Bio-Techne TECH Stock Holding History

Keating Financial Advisory Services’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.03K Buy
57
+19
+50% +$1.03K ﹤0.01% 1655
2026
Q1 		$1.99K Sell
38
-27
-42% -$1.62K ﹤0.01% 1849
2025
Q4 		$3.82K Buy
+65
New +$3.95K ﹤0.01% 1373

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

Keating Financial Advisory Services's TECH Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Bio-Techne (TECH) stake by 50% in Q2 2026, buying an estimated $1.03K and bringing the position to 57 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Keating Financial Advisory Services first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 559 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Keating Financial Advisory Services held 57 shares of Bio-Techne worth $4.03K as of Q2 2026.
  • Keating Financial Advisory Services bought 19 Bio-Techne shares in Q2 2026, an estimated $1.03K.
  • Bio-Techne made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1655 holding.
  • Keating Financial Advisory Services first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • 559 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.